Infinity FX proves to be an excellent resistance management tool with three modes of action for broadleaf weed control, including Canada’s newest cereal herbicide, Group 27
Calgary, Alberta (April 13, 2016) – Bayer has announced the launch of Infinity® FX, a new cereal herbicide that provides growers with outstanding control of cleavers and kochia, as well as managing other tough to control weeds. With the combination of three different herbicide Groups, Infinity FX offers growers exceptional resistance management through increased herbicide activity on the same weed species.
“At Bayer, we are dedicated to developing tools for growers that promote sustainable weed management practices without sacrificing weed control,” says Ian Scholer, Portfolio Manager – Cereal Broadleaf Herbicides. “By incorporating a Group 27, 6 and 4 herbicide, Infinity FX is the newest option for growers looking to do their part in preventing the onset of herbicide resistance, while still managing broadleaf weeds.”
With both systemic and contact properties, Infinity FX provides growers with fast-acting control on the toughest broadleaf weeds—including cleavers, kochia, wild buckwheat in addition to volunteer flax.
“Growers and retailers asked Bayer for a product that offers increased cleaver and kochia control while combating the looming threat of herbicide resistance,” says Scholer. “We developed Infinity FX as a result of those requests, in an effort to empower Canadian growers with the tools they need to assist them in the challenges they face on their operation.”
Offered in convenient 40 acre co-packs, Infinity FX has a wide window of application and is tank-mix friendly. Growers are encouraged to talk to their local retailers for more information.
– 30 –
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
Note to editors:
Print-quality photos can be downloaded from our website at www.news.bayer.com
TV and multimedia editors can download or order updated film footage about Bayer free of charge at www.tv-footage.bayer.com.
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.